Concentrations of von Willebrand factor in diabetes

Por Parving, Hans-Henrik
Publicado em 1996

Prognosis in diabetic nephropathy: Authors' reply

Por Parving, Hans-Henrik, Hommel, Eva
Publicado em 1989

Direct renin inhibition in chronic kidney disease

Por Persson, Frederik, Rossing, Peter, Parving, Hans-Henrik
Publicado em 2013

Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review

Por Persson, Frederik, Lindhardt, Morten, Rossing, Peter, Parving, Hans-Henrik
Publicado no J Renin Angiotensin Aldosterone Syst (2016)

Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With N...

Por Lajer, Maria, Jorsal, Anders, Tarnow, Lise, Parving, Hans-Henrik, Rossing, Peter
Publicado em 2010

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

Por Andersen, Sten, Mischak, Harald, Zürbig, Petra, Parving, Hans-Henrik, Rossing, Peter
Publicado em 2010

Vitamin D Levels, Microvascular Complications, and Mortality in Type 1 Diabetes

Por Joergensen, Christel, Hovind, Peter, Schmedes, Anne, Parving, Hans-Henrik, Rossing, Peter
Publicado em 2011

Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes: An Inception Cohort Study

Por Hovind, Peter, Rossing, Peter, Tarnow, Lise, Johnson, Richard J., Parving, Hans-Henrik
Publicado em 2009

Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study

Por Gæde, Peter, Oellgaard, Jens, Kruuse, Christina, Rossing, Peter, Parving, Hans-Henrik, Pedersen, Oluf
Publicado no Diabetologia (2019)

Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria

Por Mathiesen, Elisabeth R, Hommel, Eva, Hansen, Henrik P, Smidt, Ulla M, Parving, Hans-Henrik
Publicado em 1999

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients

Por Nielsen, Stine Elkjaer, Sugaya, Takeshi, Hovind, Peter, Baba, Tsuneharu, Parving, Hans-Henrik, Rossing, Peter
Publicado em 2010

Vitamin D Levels and Mortality in Type 2 Diabetes

Por Joergensen, Christel, Gall, Mari-Anne, Schmedes, Anne, Tarnow, Lise, Parving, Hans-Henrik, Rossing, Peter
Publicado em 2010

The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers

Por Schievink, Bauke, de Zeeuw, Dick, Parving, Hans-Henrik, Rossing, Peter, Lambers Heerspink, Hiddo Jan
Publicado no Br J Clin Pharmacol (2015)

Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2...

Por Oellgaard, Jens, Gæde, Peter, Rossing, Peter, Rørth, Rasmus, Køber, Lars, Parving, Hans-Henrik, Pedersen, Oluf
Publicado no Diabetologia (2018)

Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy

Por Persson, Frederik, Lewis, Julia B., Lewis, Edmund J., Rossing, Peter, Hollenberg, Norman K., Parving, Hans-Henrik
Publicado em 2010

Aliskiren in Combination with Losartan Reduces Albuminuria Independent of Baseline Blood Pressure in Patients with Type 2 Diabetes and Nephropathy

Por Persson, Frederik, Lewis, Julia B., Lewis, Edmund J., Rossing, Peter, Hollenberg, Norman K., Parving, Hans-Henrik
Publicado em 2011

Renal Dysfunction in the Presence of Normoalbuminuria in Type 2 Diabetes: Results from the DEMAND Study

Por Dwyer, Jamie P., Parving, Hans-Henrik, Hunsicker, Lawrence G., Ravid, Moti, Remuzzi, Giuseppe, Lewis, Julia B.
Publicado em 2012

Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial

Por Gæde, Peter, Oellgaard, Jens, Carstensen, Bendix, Rossing, Peter, Lund-Andersen, Henrik, Parving, Hans-Henrik, Pedersen, Oluf
Publicado no Diabetologia (2016)

Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception coh...

Por Ferreira, Isabel, Hovind, Peter, Schalkwijk, Casper G., Parving, Hans-Henrik, Stehouwer, Coen D. A., Rossing, Peter
Publicado no Diabetologia (2017)

Osteoprotegerin and Mortality in Type 2 Diabetic Patients

Por Reinhard, Henrik, Lajer, Maria, Gall, Mari-Anne, Tarnow, Lise, Parving, Hans-Henrik, Rasmussen, Lars M., Rossing, Peter
Publicado em 2010